MUSCULAR INVASIVE BLADDER CANCER (MIBC)

Clinical trials for MUSCULAR INVASIVE BLADDER CANCER (MIBC) explained in plain language.

Never miss a new study

Get alerted when new MUSCULAR INVASIVE BLADDER CANCER (MIBC) trials appear

Sign up with your email to follow new studies for MUSCULAR INVASIVE BLADDER CANCER (MIBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo aims to tackle aggressive bladder cancer

Disease control Recruiting now

This clinical trial is testing whether a combination of two drugs, SHR-A2102 and adebrelimab, works better than standard chemotherapy for people with muscle-invasive bladder cancer. The treatment is given before and after surgery to remove the bladder. The study involves 840 part…

Matched conditions: MUSCULAR INVASIVE BLADDER CANCER (MIBC)

Phase: PHASE2, PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Jul 15, 2026 00:00 UTC

MUSCULAR INVASIVE BLADDER CANCER (MIBC)

Get alerted when new MUSCULAR INVASIVE BLADDER CANCER (MIBC) trials appear

New drug duo aims to tackle aggressive bladder cancer